Cite
HARVARD Citation
Balabanski, L. et al. (2020). Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations. Technology in cancer research & treatment. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Balabanski, L. et al. (2020). Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations. Technology in cancer research & treatment. p. . [Online].